Dr. Wee Joo Chng to Receive Asian Myeloma Network Distinguished Service Award
News related to:International Myeloma Foundation · 2 min read
SHANGHAI, Oct. 16, 2026 /CourierPR/ -- The International Myeloma Foundation (IMF) will honor Dr. Wee Joo Chng with the Asian Myeloma Network (AMN) Distinguished Service Award at the 10th AMN Summit in Shanghai, China, on Saturday, October 17, 2026. This year’s summit, taking place from October 15-18, 2026, will be the largest gathering of myeloma specialists, patients, and caregivers in Asia.
Dr. Chng, a renowned myeloma specialist and Chairman of the AMN, will receive the award for his significant contributions to the field. He is a member of the IMF Scientific Advisory Board and holds several prestigious positions, including Vice President of Biomedical Sciences Research at the Office of the Deputy President at the National University of Singapore, Yong Loo Lin Professor in Medical Oncology, and Senior Consultant at the National University Cancer Institute.
Dr. Chng’s journey in myeloma research began with his medical degree from the University of Leeds, UK, followed by a residency in internal medicine in the UK. He completed his fellowship in hematology in Singapore and later received an A*STAR international fellowship in 2004 to study multiple myeloma genetics at the Mayo Clinic. His research focuses on using high-resolution global genomic techniques to understand the biology, identify drug targets, and improve disease prognosis in hematological malignancies.
Throughout his career, Dr. Chng has received numerous accolades, including the 2021 Yong Loo Lin School of Medicine Graduate Mentor of the Year (GRAMAY) Award, the 2020 Brian G.M. Durie Outstanding Achievement Award, and the 2020 National Day Awards, Public Administration Silver Medal. He has also been recognized with the 2017 NUS YYL SOM Outstanding Researcher of the Year Award and the 2017 NMRC Senior Translational (STaR) Research Award.
Dr. Chng’s contributions extend beyond his research. He has co-authored numerous publications in prestigious medical journals such as Leukemia, Haematologica, Blood, Cancer Research, and Blood Cancer Journal. He is a member of several professional organizations, including the American Society of Hematology (ASH), American Association of Cancer Research (AACR), International Myeloma Working Group (IMWG), and the Singapore Society of Haematology.
The IMF, founded in 1990, is the world’s leading organization dedicated to multiple myeloma. The organization serves people impacted by myeloma at every stage of the disease by combining world-class research, trusted education, global advocacy, and direct support. The IMF’s global network includes more than 380 internationally renowned researchers and clinicians who establish the guidelines that shape how myeloma is diagnosed, treated, and managed across the globe.
The 10th AMN Summit will feature a variety of programs, including clinical trials, basic myeloma research, physician training, and patient support. The IMF will present the AMN Distinguished Service Award to Dr. Chng during the summit’s award dinner.